ArticleJournal of personalized medicine2022

A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease.

Jia-Ling Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.